'Science' says Abbott is a Top Employer

AbbottThe journal Science has recognized Abbott (NYSE: ABT) as a Top 20 Employer. The global healthcare company ranked No. 14 overall, receiving high marks for social responsibility, employee loyalty, and having a work culture that aligns with the values of its employees.

This marks the 12th time Abbott has been included in Science magazine's annual ranking, which is voted on by scientists who are asked to select the companies they considered best, average, and worst employers. The complete rankings are available online and in the Oct. 30, 2015, print edition of Science.

"The people who work at Abbott are passionate about advancing science and technology, and we're happy to support them in reaching their professional best," said Robert Miller, Ph.D., co-chair of Abbott's Scientific Governing Board, which oversees the company's 1,700 scientists. "With our global footprint and diverse business profile, scientists can have multiple careers within the same company at Abbott."

As part of its mission to bring new products and technologies to the world, Abbott this year brought renewed focus to the concept of "open innovation" with business partners, universities, and start-ups. This increases opportunities for Abbott's scientists to work on new technologies and inventions.

In Abbott's diagnostics business, an example of open innovation includes a recent partnership with the U.S. Department of Defense to develop a portable blood test to rapidly diagnose concussions and traumatic brain injury. In the company's nutrition business, academic partnerships with the University of Illinois Urbana-Champaign, the University of Singapore and the University of Granada in Spain are helping Abbott scientists explore the cognitive benefits of nutrition.

Scientists at Abbott are given opportunities to advance science, technology, medicine and nutrition to help people live fuller and more complete lives. The company recognizes this commitment through a number of internal recognition efforts, including chairman's awards, president's awards, and patent and inventor awards. The company honors its most distinguished scientists and engineers with induction into the prestigious Volwiler Society, named for the late Ernest H. Volwiler, Ph.D., an internationally recognized scientist and former Abbott president and chairman of the board.

In addition to being honored for workplace leadership by Science, FORTUNE magazine has named Abbott as one of "America's Most Admired Companies" every year since the list's inception in 1983. Working Mother and DiversityInc magazines have also ranked Abbott as a top employer, and the National Association for Female Executives again named Abbott among the Top 50 Companies for Executive Women in 2015.

About the 2015 Science Survey
Science conducted a web-based survey aimed at determining the companies in the biotechnology and pharmaceutical industries with the best reputations as employers. Survey respondents were asked to select the companies they considered best, average, and worst employers. They then rated these companies on 23 different attributes including Image, Financial Prowess, Leadership and Direction, Work Culture/Environment, Location, and Academic and Intellectual Challenge. The report is based on a total sample of 5,701 people. The vast majority of survey participants came from North America (58%), Europe (27%), and Asia/Pacific Rim (11%).

About Abbott
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

Most Popular Now

A great place to do great things: Developing game-…

Science has spoken: Abbott (NYSE: ABT) is, again, among the best science-based companies to work for in the world. For the 14th year, the journal Science today recognized...

FDA accepts regulatory submission for Lynparza in …

AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) today announced that the US Food and Drug Administration (FDA) has accepted and granted...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Three of the most deadly cancers get critical fund…

Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the de...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Scientists find where HIV 'hides' to evade detecti…

In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memor...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

China's out of control 'silent killer' affects one…

More than one-third of adults in China have high blood pressure - often dubbed the "silent killer" for its lack of symptoms - but only about one in 20 have the condition ...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]